Form 4 filed by Reardon Andrew
Reardon Andrew filed this Form 4 on LGND (LIGAND PHARMACEUTICALS INC) with 15 transaction rows and 0 holding rows, accepted by EDGAR 2026-11-04 21:23:00 UTC.
- Accession
- 0001950232-26-000006
- Filer
- CIK 1950232
- Filed
- 2026-11-04
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Issuer and reporting owners
Issuer: LGND · LIGAND PHARMACEUTICALS INC (CIK 886163)
- Reardon Andrew officer (CLO & Secretary)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-11-02 | M exercised | +5,000 | $52.27 | 36,854 | D |
| Common Stock | 2026-11-02 | S sold | -283 | $307.3917 | 36,571 | D |
| Common Stock | 2026-11-02 | S sold | -708 | $308.4308 | 35,863 | D |
| Common Stock | 2026-11-02 | S sold | -522 | $309.9097 | 35,341 | D |
| Common Stock | 2026-11-02 | S sold | -490 | $310.6149 | 34,851 | D |
| Common Stock | 2026-11-02 | S sold | -520 | $311.7178 | 34,331 | D |
| Common Stock | 2026-11-02 | S sold | -634 | $312.8543 | 33,697 | D |
| Common Stock | 2026-11-02 | S sold | -403 | $313.7492 | 33,294 | D |
| Common Stock | 2026-11-02 | S sold | -80 | $314.58 | 33,214 | D |
| Common Stock | 2026-11-02 | S sold | -280 | $317.9071 | 32,934 | D |
| Common Stock | 2026-11-02 | S sold | -440 | $318.7265 | 32,494 | D |
| Common Stock | 2026-11-02 | S sold | -320 | $319.9698 | 32,174 | D |
| Common Stock | 2026-11-02 | S sold | -200 | $321.44 | 31,974 | D |
| Common Stock | 2026-11-02 | S sold | -120 | $323.1433 | 31,854 | D |
| Employee Stock Option (right to buy) derivative | 2026-11-02 | M exercised | -5,000 | $0 | 24,104 | D |